Multiple Sclerosis – Page 2 – Medical Marijuana

Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis- a double-blind, placebo controlled, crossover study

Interaction Between The Protective Effects Of Cannabidiol And Palmitoylethanolamide In Experimental Model Of Multiple Sclerosis In C57bl6 Mice

Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis- a randomized, double-blind, placebo-controlled, crossover study

Effects of cannabis on cognitive function in patients with multiple sclerosis

Clinical experiences with cannabinoids in spasticity management in multiple sclerosis

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

Cannabinoids in the management of spasticity associated with multiple sclerosis

Cannabinoids in multiple sclerosis (CAMS) study- safety and efficacy data for 12 months follow up

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study)- multicentre randomised placebo-controlled trial

Cannabinoid Modulation of Neuroinflammatory Disorders